Investment Summary

Health Enterprise Partners Invests In Aware Recovery Care

On January 29, 2021, private equity firm Health Enterprise Partners invested in healthcare services company Aware Recovery Care

Investment Highlights
  • This is Health Enterprise Partners’ 13th transaction in the Healthcare Services sector.
  • This is Health Enterprise Partners’ 27th transaction in the United States.
  • This is Health Enterprise Partners’ 3rd transaction in Connecticut.

Investment Summary

Date 2021-01-29
Target Aware Recovery Care
Sector Healthcare Services
Investor(s) Health Enterprise Partners
Deal Type Growth Capital

Target

Aware Recovery Care

Wallingford, Connecticut, United States
Aware Recovery Care engages in the in-home mental health and substance use disorder treatment industry, representing true innovation. Supported by a specially-trained team of addiction professionals, Aware offers a best-in-class in-home addiction treatment program backed by both logic and data. Aware Recovery Care is based in Wallingford, Connecticut.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor
DESCRIPTION

Health Enterprise Partners is a private equity firm focused on the healthcare technology, tech-enabled services, and healthcare services. Specific areas of interest include behavioral health IT, consumer engagement platforms, data security, genomics data analytics, payor services, tech-enabled substance abuse management, social determinants of health, and virtual care. The Firm generally pursues growth equity investments and small buy-and-builds. Health Enterprise Partners was formed in 2007 and is headquartered in New York City.


DEAL STATS #
Overall 27 of 32
Sector (Healthcare Services) 13 of 14
Type (Growth Capital) 13 of 15
State (Connecticut) 3 of 3
Country (United States) 27 of 32
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-19 Bardy Diagnostics

Charlotte, North Carolina, United States

Bardy Diagnostics develops and markets the Carnation Ambulatory Monitor, a non-invasive P-wave centric ambulatory cardiac monitor and arrhythmia detection device that generates superior clinical data, improves patient compliance and fits within varied hospital and cardiology workflows and reimbursement concerns. Bardy Diagnostics is based in Charlotte, North Carolina.

Sell $375M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-02 AxiaMed

Santa Barbara, California, United States

AxiaMed is a healthcare financial technology company specializing in payment integration and security. AxiaMed’s integrated payments technology platform, Payment Fusion, improves the financial performance of healthcare providers through integration with various revenue cycle, practice management, EHRs, and other software systems, enhancing interoperability and payment options across the entire ecosystem of healthcare payments between patients, providers and payers. AxiaMed is based in Santa Barbara, California.

Sell -